UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$1.56B |
| 2 |
Eaton
ETN
|
$585M |
| 3 |
SPDR Gold Trust
GLD
|
$582M |
| 4 |
Hewlett Packard
HPE
|
$514M |
| 5 |
Southwest Airlines
LUV
|
$510M |
Top Sells
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
$660M |
| 2 |
Phillips 66
PSX
|
$549M |
| 3 |
Microsoft
MSFT
|
$513M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$480M |
| 5 |
Boeing
BA
|
$458M |
Sector Composition
| 1 | Technology | 19.9% |
| 2 | Financials | 12.02% |
| 3 | Healthcare | 8.45% |
| 4 | Consumer Discretionary | 8.12% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Western Union
WU
$2.82B
| $26.7M | ﹤0.01% |
2,519,240
+29,997
| +1% | +$317K |
|
1602
Celldex Therapeutics
CLDX
$1.51B
| $26.6M | ﹤0.01% |
1,468,240
+1,078,443
| +277% | +$19.6M |
|
1603
C.H. Robinson
CHRW
$15.1B
| $26.6M | ﹤0.01% |
259,325
-136,702
| -35% | -$14M |
|
1604
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$428M
| $26.5M | ﹤0.01% |
323,605
+14,007
| +5% | +$1.15M |
|
|
PDX
1605
PIMCO Dynamic Income Strategy Fund
PDX
$1.11B
| $26.5M | ﹤0.01% |
1,079,136
+46,711
| +5% | +$1.15M |
|
1606
Rocket Companies
RKT
$40.3B
| $26.5M | ﹤0.01% |
2,193,020
+852,599
| +64% | +$10.3M |
|
1607
Haemonetics
HAE
$2.61B
| $26.4M | ﹤0.01% |
416,097
+223,585
| +116% | +$14.2M |
|
1608
Organon & Co
OGN
$2.52B
| $26.4M | ﹤0.01% |
1,774,328
-1,518,225
| -46% | -$22.6M |
|
|
QXO
1609
QXO Inc
QXO
$13.9B
| $26.3M | ﹤0.01% |
1,945,923
+256,267
| +15% | +$3.47M |
|
1610
REV Group
REVG
$3B
| $26.2M | ﹤0.01% |
830,322
+152,479
| +22% | +$4.82M |
|
1611
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$2.04B
| $26.2M | ﹤0.01% |
1,207,836
+213,537
| +21% | +$4.64M |
|
1612
Apogee Therapeutics
APGE
$2.21B
| $26.2M | ﹤0.01% |
701,909
+160,623
| +30% | +$6M |
|
1613
Assured Guaranty
AGO
$3.95B
| $26.1M | ﹤0.01% |
296,799
+17,879
| +6% | +$1.58M |
|
|
HIMU
1614
iShares High Yield Muni Active ETF
HIMU
$1.91B
| $26.1M | ﹤0.01% |
+527,760
| New | +$26.1M |
|
1615
Radian Group
RDN
$4.79B
| $26.1M | ﹤0.01% |
790,412
+413,650
| +110% | +$13.7M |
|
1616
Maximus
MMS
$4.99B
| $26.1M | ﹤0.01% |
383,040
-58,367
| -13% | -$3.98M |
|
1617
Takeda Pharmaceutical
TAK
$48.3B
| $26.1M | ﹤0.01% |
1,754,562
+92,930
| +6% | +$1.38M |
|
1618
Hexcel
HXL
$5.1B
| $26.1M | ﹤0.01% |
476,381
-617,481
| -56% | -$33.8M |
|
1619
RenaissanceRe
RNR
$11.5B
| $26M | ﹤0.01% |
108,290
-187,972
| -63% | -$45.1M |
|
1620
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.42B
| $25.9M | ﹤0.01% |
308,738
-7,839
| -2% | -$658K |
|
1621
Enova International
ENVA
$3.09B
| $25.9M | ﹤0.01% |
268,159
+25,069
| +10% | +$2.42M |
|
1622
Onto Innovation
ONTO
$5B
| $25.8M | ﹤0.01% |
212,723
-20,476
| -9% | -$2.48M |
|
|
JBTM
1623
JBT Marel Corporation
JBTM
$7.36B
| $25.8M | ﹤0.01% |
210,879
-73,122
| -26% | -$8.94M |
|
1624
BOK Financial
BOKF
$7.19B
| $25.7M | ﹤0.01% |
246,437
+103,110
| +72% | +$10.7M |
|
1625
Liberty Global Class C
LBTYK
$4.14B
| $25.6M | ﹤0.01% |
2,142,119
+1,234,291
| +136% | +$14.8M |
|